195 related articles for article (PubMed ID: 36519020)
1. Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study.
Yu S; You C; Yan R; Chen H; Chen C; Xu S; Gonzalez M; Chen R; Kang M; Chen S
Transl Lung Cancer Res; 2022 Nov; 11(11):2275-2288. PubMed ID: 36519020
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for predicting recurrence and metastasis of stage IA lung adenocarcinoma treated by videoassisted thoracoscopic lobectomy.
Huang Z; Peng K; Hong Z; Zhang P; Kang M
Asian J Surg; 2022 Dec; 45(12):2691-2699. PubMed ID: 35153141
[TBL] [Abstract][Full Text] [Related]
3. A Nomogram Based on Consolidation Tumor Ratio Combined with Solid or Micropapillary Patterns for Postoperative Recurrence in Pathological Stage IA Lung Adenocarcinoma.
Zhang L; Liu J; Yang D; Ni Z; Lu X; Liu Y; Liu Z; Wang H; Feng M; Zhang Y
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510119
[TBL] [Abstract][Full Text] [Related]
4. Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study.
Xu SJ; Chen RQ; Tu JH; You CX; Chen C; Zhang ZF; Divisi D; Migliore M; Bongiolatti S; Durand M; Sato M; Kuroda H; Yang CF; Yu SB; Chen SC
Transl Lung Cancer Res; 2023 May; 12(5):1078-1092. PubMed ID: 37323166
[TBL] [Abstract][Full Text] [Related]
5. A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma.
Xu SJ; Tu JH; Chen H; Yan RH; Chen RQ; Chen C; You CX; Zhang ZF; Yu SB; Chen SC
Ann Surg Oncol; 2023 Sep; 30(9):5843-5853. PubMed ID: 37219654
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor.
Ran P; Tan T; Zhou H; Li J; Yang H; Li J; Zhang J
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983680
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
8. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
9. A validated model to predict spread through air space in lung adenocarcinoma.
Zheng Y; Han X; Li H; Luo Q; Ding C; Zhang K; Fan J; Zeng W; Shi H
J Thorac Dis; 2024 Apr; 16(4):2296-2313. PubMed ID: 38738222
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
Zeng Y; Mayne N; Yang CJ; D'Amico TA; Ng CSH; Liu CC; Petersen RH; Rocco G; Brunelli A; Liu J; Liu Y; Huang W; He J; Wang W; Jiang L; Cui F; Wang W; Liang W; He J;
Ann Surg Oncol; 2019 Jul; 26(7):2053-2062. PubMed ID: 30900105
[TBL] [Abstract][Full Text] [Related]
11. Dual-energy CT may predict post-operative recurrence in early-stage glottic laryngeal cancer: a novel nomogram and risk stratification system.
Zhang H; Zou Y; Tian F; Li W; Ji X; Guo Y; Li Q; Sun S; Sun F; Shen L; Xia S
Eur Radiol; 2022 Mar; 32(3):1921-1930. PubMed ID: 34762148
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
Qian J; Xu J; Wang S; Qian F; Yang W; Zhang B; Zhang Y; Nie W; Lou Y; Lu J; Zhang X; Zhang W; Chu T; Zhong H; Fang W; Zhao H; Han B
Ann Surg Oncol; 2019 Aug; 26(8):2392-2400. PubMed ID: 31011907
[TBL] [Abstract][Full Text] [Related]
13. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.
Huang W; Zhang H; Zhang Z; Zhang B; Sun X; Huo Y; Feng Y; Tian P; Mo H; Wang C
J Surg Oncol; 2022 Mar; 125(4):796-808. PubMed ID: 34862621
[TBL] [Abstract][Full Text] [Related]
14. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J
Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictors.
Wang Y; Zheng D; Luo J; Zhang J; Pompili C; Ujiie H; Matsuura N; Chen H; Yao F
Transl Lung Cancer Res; 2021 May; 10(5):2205-2217. PubMed ID: 34164270
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
17. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.
Shigefuku S; Ito H; Miura J; Kikuchi A; Isaka T; Adachi H; Nakayama H; Ikeda N
Ann Surg Oncol; 2023 Feb; 30(2):830-838. PubMed ID: 36282457
[TBL] [Abstract][Full Text] [Related]
19. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I-III Renal Cell Carcinoma.
Zhang H; Yin F; Chen M; Yang L; Qi A; Cui W; Yang S; Wen G
Front Oncol; 2021; 11():742547. PubMed ID: 35155180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
